Developer docs
API playgroundTry for free, no card

Search company profiles

Formedix

Full company profile

uuid000f3c5

Namestring
Formedix
Legal namestring
Formedix LLC
Websiteurl
formedix.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

Formedix is a clinical trial software company that automates the standardization, validation, and submission of clinical study data to regulatory authorities. Its core technology centers on enforcing CDISC data standards (SDTM, ADaM, SEND, define.xml) for submissions to the FDA, PMDA, and NMPA, and it packages this capability into Pinnacle 21 Enterprise, a modular platform comprising a Clinical Metadata Repository (CMDR), CRF design and EDC visualization tools, automated data validation, define.xml generation, Study Data Reviewer's Guide automation, SDTM specification management, and external vendor data exchange. A free Pinnacle 21 Community edition offers basic validation utilities (Validator, Define.xml Generator, Data Converter, ClinicalTrials.gov Miner) as a top-of-funnel channel for enterprise sales. Native integrations with Medidata Rave and Veeva Vault embed the software into the dominant EDC environments used by clinical operations teams.

Formedix primarily serves pharmaceutical companies running clinical trials, with secondary reach into contract research organizations (CROs) and biotechnology companies that need consistent, submission-ready datasets. The company's value proposition is the reduction of manual rework and rejection risk in regulatory submissions, delivered through pre-built, standards-compliant metadata and validation rules accumulated over more than two decades.

Formedix was a privately held LLC until it was acquired by US-based Certara Inc. in October 2023, after which its technology and products were folded into Certara's software portfolio. Pricing is not publicly disclosed, and the company is no longer reported as an independent operating entity; under Certara, the offering is delivered alongside complementary products such as Phoenix, GlobalSubmit, Simcyp, and SEND Explorer, and is covered by Certara's ISO 27001-certified Information Security Management System.

Short descriptiontext

Formedix provides clinical trial automation software that standardizes, validates, and packages study data for CDISC-compliant regulatory submissions. It serves pharmaceutical companies, CROs, and biotechs, and has been a Certara subsidiary since October 2023.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBurlington, United States
HQ citystring
Burlington
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial automation, CDISC compliance software, clinical data standardization, regulatory submission software, clinical metadata repository
Industry2 codes
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGACAL
Site Data Management Support (EDC/Source/SDV Readiness)
NAICS code1 code
  • Computer Systems Design Services541512
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Clinical Trial Data Standardization Software
Social media profiles1 record
Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Formedix develops and supplies clinical trial automation software focused on data standardization and CDISC compliance. Its platform helps pharmaceutical, biotech, and CRO organizations design clinical studies, build compliant case report forms, validate datasets, and generate submission-ready deliverables for FDA, PMDA, and NMPA regulatory authorities. Following its October 2023 acquisition by Certara Inc., Formedix's technology has been integrated into Certara's Pinnacle 21 Enterprise software platform.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Formedix was acquired by Certara in October 2023. Formedix's technology and expertise in clinical trial automation, data standardization, and CDISC compliance was integrated into Certara's product portfolio. The combined offering centers on Pinnacle 21 Enterprise, a platform-plus-modules architecture that provides end-to-end clinical data standardization from study design through regulatory submission. The platform includes core modules for Clinical Metadata Repository, Clinical Trial Design, CRF Design/EDC Build, External Data Exchange, Clinical Data Validation, Issue Management, Define.xml generation, Reviewer's Guide creation, and SDTM Specification Management. Pinnacle 21 Enterprise is offered alongside a free Community version for basic validation needs.

Product and service2 records
1Pinnacle 21 Enterprise
CategoryClinical Trial Data Standardization Software
Description

Clinical data standardization software platform that enables clinical teams to standardize, validate, and harmonize data for submission-ready deliverables, achieving conformance with CDISC standards for FDA, PMDA, and NMPA regulatory submissions.

2Pinnacle 21 Community
CategoryClinical Trial Validation Software
Description

Free community version of validation software offering basic validation capabilities, including Validator, Define.xml Generator, Data Converter, and ClinicalTrials.gov Miner tools.

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-10-01
Description

In October 2023, Certara Inc. acquired Formedix LLC to enhance its clinical trial automation capabilities through Formedix's data standardization and CDISC compliance expertise. This acquisition strengthened Certara's position in clinical data management and regulatory submission solutions.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Castor offers a cloud-native EDC platform with built-in data standardization capabilities, increasingly competing with Formedix in the SMB biotech and academic clinical trial segment.

TypeDirect peer
Description

Veeva's Vault CTMS and Vault EDC compete in the same clinical trial data management space, with Formedix explicitly integrating with Veeva Vault via its CRF Creator module to serve overlapping pharma/CRO customers.

TypeDirect peer
Description

Anju Software provides a suite of clinical trial applications including EDC, CTMS, and data management modules, competing directly with Formedix's platform in mid-market pharma and CRO segments.

TypeEmerging player
Description

Saama provides AI-driven clinical trial analytics and data management solutions, increasingly overlapping with Formedix's downstream data validation and submission readiness workflow.

TypeEmerging player
Description

eClinical Solutions offers the elluminate Clinical Data Cloud with integrated EDC, CDISC mapping, and submission analytics — directly competing with Formedix in clinical data standardization for pharma and CRO sponsors.

TypeDirect peer
Description

Clario (formed from the merger of Bioclinica and ERT) delivers eCOA, imaging, and clinical trial endpoint solutions with a focus on data quality and regulatory submission readiness, overlapping with Formedix's regulatory submission positioning.

TypeDirect peer
Description

Medidata (a Dassault Systèmes company) offers the Rave EDC platform and adjacent clinical trial data management solutions, including CDISC validation capabilities, serving the same pharma, biotech, and CRO customer base as Formedix.

TypeDirect peer
Description

ArisGlobal's LifeSphere platform offers clinical trial data management, regulatory information management, and safety solutions — addressing the same pharma R&D and submission workflows as Formedix.

TypeEmerging player
Description

OpenClinica provides open-source and cloud EDC solutions with CDISC-aware data capture, representing an emerging alternative to Formedix for cost-sensitive sponsors and CROs.

10Oracle Health Sciences
TypeDirect peer
Description

Oracle's Clinical One platform provides unified clinical trial data capture, management, and submission solutions for large pharma — directly competing with Formedix's standardization and CDISC compliance offerings.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Formedix

Clinical Trial Data Standardization Softwareformedix.com

Formedix provides clinical trial automation software that standardizes, validates, and packages study data for CDISC-compliant regulatory submissions. It serves pharmaceutical companies, CROs, and biotechs, and has been a Certara subsidiary since October 2023.

What Formedix does

Formedix is a clinical trial software company that automates the standardization, validation, and submission of clinical study data to regulatory authorities. Its core technology centers on enforcing CDISC data standards (SDTM, ADaM, SEND, define.xml) for submissions to the FDA, PMDA, and NMPA, and it packages this capability into Pinnacle 21 Enterprise, a modular platform comprising a Clinical Metadata Repository (CMDR), CRF design and EDC visualization tools, automated data validation, define.xml generation, Study Data Reviewer's Guide automation, SDTM specification management, and external vendor data exchange. A free Pinnacle 21 Community edition offers basic validation utilities (Validator, Define.xml Generator, Data Converter, ClinicalTrials.gov Miner) as a top-of-funnel channel for enterprise sales. Native integrations with Medidata Rave and Veeva Vault embed the software into the dominant EDC environments used by clinical operations teams.

Formedix primarily serves pharmaceutical companies running clinical trials, with secondary reach into contract research organizations (CROs) and biotechnology companies that need consistent, submission-ready datasets. The company's value proposition is the reduction of manual rework and rejection risk in regulatory submissions, delivered through pre-built, standards-compliant metadata and validation rules accumulated over more than two decades.

Formedix was a privately held LLC until it was acquired by US-based Certara Inc. in October 2023, after which its technology and products were folded into Certara's software portfolio. Pricing is not publicly disclosed, and the company is no longer reported as an independent operating entity; under Certara, the offering is delivered alongside complementary products such as Phoenix, GlobalSubmit, Simcyp, and SEND Explorer, and is covered by Certara's ISO 27001-certified Information Security Management System.

Formedix firmographics

Firmographics
Name
Formedix
Legal name
Formedix LLC
Website
https://formedix.com
Company type
Private
Founded year
2000
Operating status
Acquired
Headcount range
11–50 employees
Short description
Formedix provides clinical trial automation software that standardizes, validates, and packages study data for CDISC-compliant regulatory submissions. It serves pharmaceutical companies, CROs, and biotechs, and has been a Certara subsidiary since October 2023.
Ownership category
akta.pro rank

Formedix industry classification

Industry
Product category
Clinical Trial Data Standardization Software
NAICS
Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAGAKAA
Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYHLAGACAL
Site Data Management Support (EDC/Source/SDV Readiness)

Keywords

  • Clinical trial automation
  • CDISC compliance software
  • Clinical data standardization
  • Regulatory submission software
  • Clinical metadata repository

Where Formedix is headquartered

Location

Headquarters

HQ city
Burlington
HQ country
United States
HQ region
North America

Markets served

Formedix business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Formedix product offering

Product offering

Core offering

Formedix develops and supplies clinical trial automation software focused on data standardization and CDISC compliance. Its platform helps pharmaceutical, biotech, and CRO organizations design clinical studies, build compliant case report forms, validate datasets, and generate submission-ready deliverables for FDA, PMDA, and NMPA regulatory authorities. Following its October 2023 acquisition by Certara Inc., Formedix's technology has been integrated into Certara's Pinnacle 21 Enterprise software platform.

Product overview

Formedix was acquired by Certara in October 2023. Formedix's technology and expertise in clinical trial automation, data standardization, and CDISC compliance was integrated into Certara's product portfolio. The combined offering centers on Pinnacle 21 Enterprise, a platform-plus-modules architecture that provides end-to-end clinical data standardization from study design through regulatory submission. The platform includes core modules for Clinical Metadata Repository, Clinical Trial Design, CRF Design/EDC Build, External Data Exchange, Clinical Data Validation, Issue Management, Define.xml generation, Reviewer's Guide creation, and SDTM Specification Management. Pinnacle 21 Enterprise is offered alongside a free Community version for basic validation needs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pinnacle 21 Enterprise Clinical data standardization software platform that enables clinical teams to standardize, validate, and harmonize data for submission-ready deliverables, achieving conformance with CDISC standards for FDA, PMDA, and NMPA regulatory submissions.
  • Pinnacle 21 Community Free community version of validation software offering basic validation capabilities, including Validator, Define.xml Generator, Data Converter, and ClinicalTrials.gov Miner tools.

Companies that use Formedix

Customer profile

Segments3 records

Ideal customer profiles3 records

Formedix technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Formedix partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Certara Inc.coreStrategic or Co-development Partner · 1 October 2023In October 2023, Certara Inc. acquired Formedix LLC to enhance its clinical trial automation capabilities through Formedix's data standardization and CDISC compliance expertise. This acquisition strengthened Certara's position in clinical data management and regulatory submission solutions.

Recent moves4 records

Expansion highlights4 records

Formedix competitors and assessment

Company assessment

Emerging players

  • Castor: Castor offers a cloud-native EDC platform with built-in data standardization capabilities, increasingly competing with Formedix in the SMB biotech and academic clinical trial segment.
  • Saama Technologies: Saama provides AI-driven clinical trial analytics and data management solutions, increasingly overlapping with Formedix's downstream data validation and submission readiness workflow.
  • eClinical Solutions: eClinical Solutions offers the elluminate Clinical Data Cloud with integrated EDC, CDISC mapping, and submission analytics — directly competing with Formedix in clinical data standardization for pharma and CRO sponsors.
  • OpenClinica: OpenClinica provides open-source and cloud EDC solutions with CDISC-aware data capture, representing an emerging alternative to Formedix for cost-sensitive sponsors and CROs.

Direct peers

  • Veeva Systems: Veeva's Vault CTMS and Vault EDC compete in the same clinical trial data management space, with Formedix explicitly integrating with Veeva Vault via its CRF Creator module to serve overlapping pharma/CRO customers.
  • Anju Software: Anju Software provides a suite of clinical trial applications including EDC, CTMS, and data management modules, competing directly with Formedix's platform in mid-market pharma and CRO segments.
  • Clario: Clario (formed from the merger of Bioclinica and ERT) delivers eCOA, imaging, and clinical trial endpoint solutions with a focus on data quality and regulatory submission readiness, overlapping with Formedix's regulatory submission positioning.
  • Medidata Solutions: Medidata (a Dassault Systèmes company) offers the Rave EDC platform and adjacent clinical trial data management solutions, including CDISC validation capabilities, serving the same pharma, biotech, and CRO customer base as Formedix.
  • ArisGlobal: ArisGlobal's LifeSphere platform offers clinical trial data management, regulatory information management, and safety solutions — addressing the same pharma R&D and submission workflows as Formedix.
  • Oracle Health Sciences: Oracle's Clinical One platform provides unified clinical trial data capture, management, and submission solutions for large pharma — directly competing with Formedix's standardization and CDISC compliance offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Formedix social profiles

Digital presence

Formedix compliance and trust

Trust signal

Compliance1 record

Formedix financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Formedix leadership team

Management profile

Number of profiles

Profiles4 records

Formedix funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Formedix M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Formedix

What does Formedix do?

Formedix develops and supplies clinical trial automation software focused on data standardization and CDISC compliance. Its platform helps pharmaceutical, biotech, and CRO organizations design clinical studies, build compliant case report forms, validate datasets, and generate submission-ready deliverables for FDA, PMDA, and NMPA regulatory authorities. Following its October 2023 acquisition by Certara Inc., Formedix's technology has been integrated into Certara's Pinnacle 21 Enterprise software platform.

Is Formedix a public or private company?

Formedix is a private company. It is classified as corporate owned and is currently acquired.

When was Formedix founded?

Formedix was founded in 2000. It employs 11 to 50 people.

Where is Formedix based?

Formedix is headquartered in Burlington, United States, in the North America region.

Who are Formedix's main competitors?

Emerging players on record are Castor, Saama Technologies, eClinical Solutions and OpenClinica. Direct peers are Veeva Systems, Anju Software, Clario, Medidata Solutions, ArisGlobal and Oracle Health Sciences.

Does Formedix have an API?

No public API is recorded for Formedix.

What industry is Formedix in?

Formedix's product category is Clinical Trial Data Standardization Software. Its primary akta.pro industry code is HLAGAKAA, Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA), with a secondary code of HLAGACAL, Site Data Management Support (EDC/Source/SDV Readiness). Its NAICS code is 541512 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals